SCHEMBL3185706

SCHEMBL3185706

CC(C)CCC(C)C(O)O

nearest known ligand 0.33

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.33
CA1 P00915 2/20 0.33
LMNA P02545 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
ALDH1A1 P00352 2/20 0.31
SLC1A3 P43003 1/20 0.30
SLC1A2 P43004 1/20 0.30
SLC1A1 P43005 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2696106 0.81 LMNA (0.48) TSHRCA1LMNA
SCHEMBL1657177 0.80 CA1 (0.39) TSHRCA1LMNATDP1ALDH1A1
SCHEMBL7352141 0.79 LMNA (0.46) LMNA
Methacrylic Acid SCHEMBL1560862 0.79 TSHR (0.36) TSHRCA1TDP1ALDH1A1SLC1A3
Hydrogen Peroxide SCHEMBL9341267 0.73 TSHR (0.46) TSHRCA1LMNATDP1ALDH1A1
Hydrogen Peroxide SCHEMBL27948378 0.73 TSHR (0.46) TSHRCA1LMNATDP1ALDH1A1
SCHEMBL11197794 0.73
SCHEMBL1055863 0.73
SCHEMBL16682354 0.73 TRPA1 (0.40) TSHRLMNA
SCHEMBL9352933 0.73 ANPEP (0.31) TSHRALDH1A1SLC1A3SLC1A2SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839179-A1 CONCENTRATED, WATER DISPERSIBLE, STABLE, FABRIC SOFTENING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1998-05-06 EP claimed
WO-1997003170-A1 CONCENTRATED, WATER DISPERSIBLE, STABLE, FABRIC SOFTENING COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 1997-01-30 WO claimed
US-5399646-A Alkylidenenorbornene polymer and process for producing the same NIPPON ZEON CO., LTD. (JP) 1995-03-21 US claimed
US-12521367-B2 Related formulations and methods related to eye irritation LEBRUN LABS LLC (US) 2026-01-13 US disclosed
US-12503615-B2 White aqueous inkjet ink XEROX CORPORATION (US) 2025-12-23 US disclosed
US-12410472-B2 Method for evaluating the eye irritation potential of chemicals IMMUNOSEARCH (FR) 2025-09-09 US disclosed
US-12115147-B2 Formulations and methods related to eye irritation LEBRUN LABS LLC (US) 2024-10-15 US disclosed
CN-118063779-A Isocyanate group modified fluorosilicone raw rubber and preparation method thereof 温州合丰胶业股份有限公司 2024-05-24 CN disclosed
US-20240092724-A1 NEW BIFUNCTIONAL (METH)ACRYLATE COMPOUND AND POLYMER MARUZEN PETROCHEMICAL CO., LTD. (JP) 2024-03-21 US disclosed
US-20240082214-A1 RELATED FORMULATIONS AND METHODS RELATED TO EYE IRRITATION LEBRUN LABS LLC (US) 2024-03-14 US disclosed
US-11919850-B2 Bifunctional (meth)acrylate compound and polymer MARUZEN PETROCHEMICAL CO., LTD. (JP) 2024-03-05 US disclosed
WO-2002100536-A1 METHOD FOR HYDROGENATING ORGANIC COMPOUNDS BY MEANS OF RU/SIO2 CATALYSTS BASF AKTIENGESELLSCHAFT (DE) 2002-12-19 WO disclosed
EP-0922689-B1 Process for the hydrogenation of alkynols using a macropous catalyst BASF AG (DE) 2002-11-13 EP disclosed
US-20020045133-A1 Method for the preparation of a semiconductor device TOKYO OHKA KOGYO CO., LTD. (JP) 2002-04-18 US disclosed
US-6130360-A Hydrogenation of alkinols using a catalyst containing macropores BASF AKTIENGESELLSCHAFT (DE) 2000-10-10 US disclosed
EP-0922689-A1 Process for the hydrogenation of alkynols using a macropous catalyst BASF AKTIENGESELLSCHAFT (DE) 1999-06-16 EP disclosed
US-5831134-A Continuous production process of tertiary alcohols by radical addition of secondary alcohols to alkenes PEROXID-CHEMIE GMBH (DE) 1998-11-03 US disclosed
EP-0492982-B1 Alkylidenenorbornene polymer and process for producing the same NIPPON ZEON CO (JP) 1995-08-02 EP disclosed
US-5399646-A Alkylidenenorbornene polymer and process for producing the same NIPPON ZEON CO., LTD. (JP) 1995-03-21 US disclosed
EP-0492982-A1 Alkylidenenorbornene polymer and process for producing the same NIPPON ZEON CO., LTD. (JP) 1992-07-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240092724-A1 NEW BIFUNCTIONAL (METH)ACRYLATE COMPOUND AND POLYMER RAD51, WDR1, TET1 TSHR 4083/4885CA1 2384/4885LMNA 2860/4885
US-11919850-B2 Bifunctional (meth)acrylate compound and polymer DNMT1, RAD51, ASH1L TSHR 3623/4885CA1 2842/4885LMNA 2601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.